These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15371898)

  • 1. Re: racial/ethnic disparities in the treatment of localized/regional prostate cancer.
    Denberg TD
    J Urol; 2004 Oct; 172(4 Pt 1):1547-8; author reply 1548. PubMed ID: 15371898
    [No Abstract]   [Full Text] [Related]  

  • 2. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic disparities in the treatment of localized/regional prostate cancer.
    Underwood W; De Monner S; Ubel P; Fagerlin A; Sanda MG; Wei JT
    J Urol; 2004 Apr; 171(4):1504-7. PubMed ID: 15017208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).
    Danley KL; Richardson JL; Bernstein L; Langholz B; Ross RK
    Cancer Causes Control; 1995 Nov; 6(6):492-8. PubMed ID: 8580296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
    Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
    Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
    Klabunde CN; Potosky AL; Harlan LC; Kramer BS
    Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic disparities in substance use disorders and outcomes in elderly prostate cancer patients.
    Chhatre S; Jayadevappa R
    J Ethn Subst Abuse; 2018; 17(2):135-149. PubMed ID: 27115724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life.
    Orom H; Biddle C; Underwood W; Homish GG; Olsson CA
    Urology; 2018 Feb; 112():132-137. PubMed ID: 28842210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.
    Rose AJ; Backus BM; Gershman ST; Santos P; Ash AS; Battaglia TA
    Med Care; 2007 May; 45(5):440-7. PubMed ID: 17446830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment patterns among racial/ethnic groups in Florida.
    Xiao H; Warrick C; Huang Y
    J Natl Med Assoc; 2009 Sep; 101(9):936-43. PubMed ID: 19806852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multidimensional view of racial differences in access to prostate cancer care.
    Pollack CE; Armstrong KA; Mitra N; Chen X; Ward KR; Radhakrishnan A; Wong MS; Bekelman JE; Branas CC; Rhodes KV; Grande DT
    Cancer; 2017 Nov; 123(22):4449-4457. PubMed ID: 28727136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
    Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
    J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial variation in receipt of quality radiation therapy for prostate cancer.
    Lee DJ; Zhao Z; Huang LC; Koyoma T; Resnick MJ; Penson DF; Barocas DA; Hoffman KE
    Cancer Causes Control; 2018 Oct; 29(10):895-899. PubMed ID: 30099628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
    Wenzel M; Nocera L; Collà Ruvolo C; Würnschimmel C; Tian Z; Shariat SF; Saad F; Briganti A; Tilki D; Graefen M; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
    J Urol; 2021 Jul; 206(1):69-79. PubMed ID: 33683934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in use of antipsychotics among patients with bipolar disorder.
    Szarek BL; Goethe JW
    J Clin Psychiatry; 2003 May; 64(5):614-5; author reply 615. PubMed ID: 12755673
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
    Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
    Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in racial and ethnic disparities after enrollment in the State Children's Health Insurance Program.
    Shone LP; Dick AW; Klein JD; Zwanziger J; Szilagyi PG
    Pediatrics; 2005 Jun; 115(6):e697-705. PubMed ID: 15930198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
    Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
    Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.